| Dr Marissa Elizabeth Bonyun, MD, MED, FRCSC | |
|
22 S Greene St, Baltimore, MD 21201-1544 | |
| (410) 328-6280 | |
| Not Available |
| Full Name | Dr Marissa Elizabeth Bonyun |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 11 Years |
| Location | 22 S Greene St, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790338341 | NPI | - | NPPES |
| 104120 | Other | CPSO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0114X | Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery | 35.139373 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Umd Prince George's Hospital Ctr | Cheverly, MD | Hospital |
| University Of Maryland Medical Center | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Maryland Orthopaedic Associates, Pa | 0042108722 | 49 |
| University Of Maryland Orthopaedic Trauma Associates, P.a. | 5294621025 | 35 |
| Dimensions Healthcare Associates Inc | 1557269743 | 103 |
News Archive
RedHill Biopharma Ltd. (NASDAQ; RDHL) (TASE: RDHL) ("RedHill" or the "Company"), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer, today announced that it has initiated a randomized, double-blind, 2-arm parallel group Phase II clinical study in the U.S. evaluating the safety and efficacy of BEKINDA™ 12 mg in patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
More than 5,000 genetic profiles of tumor DNA have been completed in a large research study by scientists at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Boston Children's Hospital designed to speed the development of personalized cancer care with precision treatments.
Always look on the bright side of life. Thanks to a new study from Concordia University, this catchy refrain offers a prescription for staying healthy during one's golden years.
Preventable rehospitalization of the nation's older adults has proved a persistent health and financial challenge for the U.S., costing Medicare hundreds of millions of dollars each year.
The Minnesota Partnership for Biotechnology and Medical Genomics announced four research projects selected for funding from the 2013 Discovery Transformation Grant Program.
› Verified 2 days ago
| Entity Name | University Of Maryland Orthopaedic Trauma Associates, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497708051 PECOS PAC ID: 5294621025 Enrollment ID: O20040227000265 |
News Archive
RedHill Biopharma Ltd. (NASDAQ; RDHL) (TASE: RDHL) ("RedHill" or the "Company"), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer, today announced that it has initiated a randomized, double-blind, 2-arm parallel group Phase II clinical study in the U.S. evaluating the safety and efficacy of BEKINDA™ 12 mg in patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
More than 5,000 genetic profiles of tumor DNA have been completed in a large research study by scientists at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Boston Children's Hospital designed to speed the development of personalized cancer care with precision treatments.
Always look on the bright side of life. Thanks to a new study from Concordia University, this catchy refrain offers a prescription for staying healthy during one's golden years.
Preventable rehospitalization of the nation's older adults has proved a persistent health and financial challenge for the U.S., costing Medicare hundreds of millions of dollars each year.
The Minnesota Partnership for Biotechnology and Medical Genomics announced four research projects selected for funding from the 2013 Discovery Transformation Grant Program.
› Verified 2 days ago
| Entity Name | University Of Maryland Orthopaedic Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740235274 PECOS PAC ID: 0042108722 Enrollment ID: O20040305000149 |
News Archive
RedHill Biopharma Ltd. (NASDAQ; RDHL) (TASE: RDHL) ("RedHill" or the "Company"), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer, today announced that it has initiated a randomized, double-blind, 2-arm parallel group Phase II clinical study in the U.S. evaluating the safety and efficacy of BEKINDA™ 12 mg in patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
More than 5,000 genetic profiles of tumor DNA have been completed in a large research study by scientists at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Boston Children's Hospital designed to speed the development of personalized cancer care with precision treatments.
Always look on the bright side of life. Thanks to a new study from Concordia University, this catchy refrain offers a prescription for staying healthy during one's golden years.
Preventable rehospitalization of the nation's older adults has proved a persistent health and financial challenge for the U.S., costing Medicare hundreds of millions of dollars each year.
The Minnesota Partnership for Biotechnology and Medical Genomics announced four research projects selected for funding from the 2013 Discovery Transformation Grant Program.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marissa Elizabeth Bonyun, MD, MED, FRCSC Po Box 636256, Cincinnati, OH 45263-6256 Ph: (513) 585-6200 | Dr Marissa Elizabeth Bonyun, MD, MED, FRCSC 22 S Greene St, Baltimore, MD 21201-1544 Ph: (410) 328-6280 |
News Archive
RedHill Biopharma Ltd. (NASDAQ; RDHL) (TASE: RDHL) ("RedHill" or the "Company"), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer, today announced that it has initiated a randomized, double-blind, 2-arm parallel group Phase II clinical study in the U.S. evaluating the safety and efficacy of BEKINDA™ 12 mg in patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
More than 5,000 genetic profiles of tumor DNA have been completed in a large research study by scientists at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Boston Children's Hospital designed to speed the development of personalized cancer care with precision treatments.
Always look on the bright side of life. Thanks to a new study from Concordia University, this catchy refrain offers a prescription for staying healthy during one's golden years.
Preventable rehospitalization of the nation's older adults has proved a persistent health and financial challenge for the U.S., costing Medicare hundreds of millions of dollars each year.
The Minnesota Partnership for Biotechnology and Medical Genomics announced four research projects selected for funding from the 2013 Discovery Transformation Grant Program.
› Verified 2 days ago
Robert J Brumback, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3333 North Calvert Street, Suite 400, Baltimore, MD 21218 Phone: 410-554-2270 Fax: 410-261-2726 | |
Dr. Milford Howarth Marchant Jr., M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 S Hanover St, Baltimore, MD 21225 Phone: 410-350-8336 Fax: 410-350-7178 | |
Dr. Michelle Ghert, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 110 S Paca St Fl 6, Baltimore, MD 21201 Phone: 614-397-2721 | |
Henry R Boucher, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 North Calvert Street, Suite 400, Baltimore, MD 21218 Phone: 410-554-2270 Fax: 410-261-2726 | |
John J Carbone, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3001 S Hanover St, Gruehn Bldg, Ste 502, Baltimore, MD 21225 Phone: 410-350-8300 | |
Dr. Dawn Laporte, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St, Rm 5210, Baltimore, MD 21287 Phone: 410-955-3134 | |
Paul C Mcafee, M.D., MBA Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 N Calvert St Ste 655, Baltimore, MD 21218 Phone: 410-554-2175 Fax: 410-554-2917 |